HCW Biologics (HCWB) Total Debt (2022 - 2025)
HCW Biologics' (HCWB) quarterly Total Debt came in at $6.8 million in Q4 2025, down 50.27% YoY from $13.7 million in Q4 2024, and little changed on a QoQ basis from $6.8 million in Q3 2025.
HCW Biologics (HCWB) Total Debt (2022 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 4 years of Total Debt data on file, last reported at $6.8 million in Q4 2025.
- Quarterly Total Debt fell 50.27% year-over-year to $6.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.8 million (down 50.27% YoY) and the FY2025 annual result came in at $6.8 million, down 50.27% from the prior year.
- Total Debt steadied at $6.8 million in Q4 2025, from $6.8 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $44.7 million in Q4 2022 to a low of $6.3 million in Q4 2023.
- A 4-year average of $11.1 million and a median of $6.8 million in 2025 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2023 — Total Debt sank 85.89% — and 2024, when it surged 117.19%.
- Tracing HCWB's Total Debt over 4 years: stood at $44.7 million in 2022, then slumped by 85.89% to $6.3 million in 2023, then surged by 117.19% to $13.7 million in 2024, then slumped by 50.27% to $6.8 million in 2025.
- The last three Total Debt figures came in at $6.8 million (Q4 2025), $6.8 million (Q3 2025), and $6.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.03 Bn | 131.18 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.93 Bn | 52.80 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.95 Bn | 36.86 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.00 Bn | 9.60 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 9.34 Bn |
| 10 | HCW Biologics | 2.87 Mn | 2.13 Mn | -93,887.00 | 6.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.81 Mn |
| Sep 30, 2025 | 6.81 Mn |
| Jun 30, 2025 | 6.79 Mn |
| Mar 31, 2025 | 13.94 Mn |
| Dec 31, 2024 | 13.69 Mn |
| Sep 30, 2024 | 12.80 Mn |
| Jun 30, 2024 | 10.02 Mn |
| Mar 31, 2024 | 8.40 Mn |
| Dec 31, 2023 | 6.30 Mn |
| Sep 30, 2023 | 6.45 Mn |
| Jun 30, 2023 | 6.50 Mn |
| Mar 31, 2023 | 6.45 Mn |
| Dec 31, 2022 | 44.68 Mn |
| Sep 30, 2022 | 6.45 Mn |